Latanoprost - Sun Pharma Advanced Research Company

Drug Profile

Latanoprost - Sun Pharma Advanced Research Company

Alternative Names: BKC-free latanoprost; Latanoprost BAK-free eye drops; Xelpros

Latest Information Update: 22 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sun Pharma Advanced Research Company
  • Class Antiglaucomas; Prostaglandins; Small molecules
  • Mechanism of Action Prostaglandin F2 alpha agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Glaucoma

Most Recent Events

  • 22 Aug 2017 No development reported - Preregistration for Glaucoma in USA (Ophthalmic)
  • 09 Jun 2015 Latanoprost licensed to Sun Pharmaceutical Industries in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top